Timothy A. Springer 13D and 13G filings for Cartesian Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-12 4:24 pm Purchase | 2024-04-08 | 13D | Cartesian Therapeutics, Inc. RNAC | Timothy A. Springer | 6,473,184 36.400% | 207 (+0.00%) | Filing |
| 2024-03-28 5:27 pm Purchase | 2024-03-26 | 13D | Cartesian Therapeutics, Inc. RNAC | Timothy A. Springer | 6,472,977 27.900% | 41,622 (+0.65%) | Filing |
| 2023-11-17 08:15 am Purchase | 2023-11-13 | 13D | Cartesian Therapeutics, Inc. RNAC | Timothy A. Springer | 6,431,355 27.700% | 4,952,803 (+334.98%) | Filing |
| 2023-09-22 7:31 pm Purchase | 2022-04-11 | 13D | Cartesian Therapeutics, Inc. RNAC | Timothy A. Springer | 1,478,553 28.900% | 389,789 (+35.80%) | Filing |
| 2021-12-27 4:05 pm Purchase | 2021-12-15 | 13D | Cartesian Therapeutics, Inc. RNAC | Timothy A. Springer | 1,088,764 28.000% | 7,040 (+0.65%) | Filing |
| 2021-12-15 5:14 pm Purchase | 2021-12-09 | 13D | Cartesian Therapeutics, Inc. RNAC | Timothy A. Springer | 1,081,724 27.800% | 127,376 (+13.35%) | Filing |
| 2021-05-27 4:11 pm Purchase | 2021-05-21 | 13D | Cartesian Therapeutics, Inc. RNAC | Timothy A. Springer | 954,348 25.300% | 156,449 (+19.61%) | Filing |
| 2020-10-23 5:19 pm Purchase | 2020-10-20 | 13D | Cartesian Therapeutics, Inc. RNAC | Timothy A. Springer | 797,899 22.300% | 184,413 (+30.06%) | Filing |
| 2020-10-15 10:10 am Purchase | 2020-10-06 | 13D | Cartesian Therapeutics, Inc. RNAC | Timothy A. Springer | 613,486 17.200% | 115,737 (+23.25%) | Filing |